配对肾脏分配研究:HLA-DR相容可提高老年肾移植生存率
该配对肾脏分配队列研究纳入675例65岁及以上供肾者的肾脏,在Eurotransplant老年项目(ESP)中比较HLA-DR抗原匹配(341例)与未匹配(334例)的移植结局。HLA-DR匹配与五年死亡风险显著降低(HR 0.71;95%CI 0.53-0.95)及移植肾衰竭和返回透析的病因特异性风险显著降低相关。匹配组冷缺血时间较长(平均差1.00小时;95%CI 0.32-1.68),供肾中位透析龄较短(2.4年 vs 4.1年)。
要点
- HLA-DR匹配与五年死亡风险显著降低相关(HR 0.71;95%CI 0.53-0.95)。
- 匹配组移植肾衰竭和返回透析风险在1年(0.55;0.35-0.87)和5年(0.73;0.53-0.99)均显著降低。
- 匹配组冷缺血时间较长(平均差1.00小时;95%CI 0.32-1.68),供肾中位透析龄较短(2.4年 vs 4.1年)。
核心结论
- 基于HLA-DR匹配的分配改善了五年患者生存和移植肾存活。
- 配对分配研究提示在老年对老年肾移植背景下HLA-DR匹配结局更优。
研究设计与样本
- 队列研究,评估ESP期间675例65岁及以上供肾者的肾脏配对分配,第一肾分配给Eurotransplant老年DR相容项目341例患者,对侧肾334例无HLA-DR抗原匹配(ESP)。
主要发现
- HLA-DR匹配与五年死亡风险显著降低相关(HR 0.71;95%CI 0.53-0.95)。
- HLA-DR匹配与移植后1年(0.55;95%CI 0.35-0.87)和5年(0.73;95%CI 0.53-0.99)移植肾衰竭和返回透析的病因特异性风险显著降低相关。
- 基于HLA-DR匹配的分配导致冷缺血时间较长(平均差1.00小时;95%CI 0.32-1.68)。
- 匹配组供肾中位透析龄为2.4年,未匹配ESP组为4.1年,匹配组显著较短。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Eurotransplant Senior Program (ESP) has expedited the chance for elderly patients with kidney failure to receive a timely transplant. This current study evaluated survival parameters of kidneys donated after brain death with or without matching for HLA-DR antigens. This cohort study evaluated the period within ESP with paired allocation of 675 kidneys from donors 65 years and older to transplant candidates 65 years and older, the first kidney to 341 patients within the Eurotransplant Senior DR-compatible Program and 334 contralateral kidneys without (ESP) HLA-DR antigen matching. We used Kaplan-Meier estimates and competing risk analysis to assess all cause mortality and kidney graft failure, respectively. The log-rank test and Cox proportional hazards regression were used for comparisons. Within ESP, matching for HLA-DR antigens was associated with a significantly lower five-year risk of mortality (hazard ratio 0.71; 95% confidence interval 0.53-0.95) and significantly lower cause-specific hazards for kidney graft failure and return to dialysis at one year (0.55; 0.35-0.87) and five years (0.73; 0.53-0.99) post-transplant. Allocation based on HLA-DR matching resulted in longer cold ischemia (mean difference 1.00 hours; 95% confidence interval: 0.32-1.68) and kidney offers with a significantly shorter median dialysis vintage of 2.4 versus 4.1 yrs. in ESP without matching. Thus, our allocation based on HLA-DR matching improved five-year patient and kidney allograft survival. Hence, our paired allocation study suggests a superior outcome of HLA-DR matching in the context of old-for-old kidney transplantation.
引用
- de Fijter J, Dreyer G, Mallat M, et al. A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program. Kidney Int. 2023. PMID: 37343659. doi:10.1016/j.kint.2023.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。